The clinical investigation of different intravesical instillation of chemotherapy after transurethral resection of bladder tumors for the treatment of superficial bladder cancer

屠凡倬,沈周俊,王先进,钟山,朱照伟,王浩飞,徐兆平,周文龙,吴瑜璇

DOI: https://doi.org/10.3760/cma.j.issn.1673-4416.2012.02.015

2012-01-01

Abstract:Objectives To investigate the efficacy and safety of intravesical instillation of pirarubicin hydrochloride(THP),hydroxycamptothecine(HCPT) or THP associated with HCPT after Transurethral Resection of Bladder Tumors(TURBT) for the treatment of Superficial Bladder cancer.Methods From Jan.2003 to Oct.2010,a total of 111 patients with newly diagnosed superficial bladder cancer undergone TURBT.The intravesical instillation of THP,HCPT,THP associated with HCPT and control was in 49,41,40 and 21 patients with bladder cancer after TURBT.The patients were received cystoscopy examination periodically to observe the recurrence rate at 0.5,1,2,3,4 and 5 years.Results The patients were followed up for 3 to 60 months,the 0.5 - year recurrence rate of the patients in the THP group,HCPT group,THP associated with HCPT and control group were 8.2％,7.3％,2.5％ and 19.0％,the 1 - year recurrence rate were 10.2％,9.8％,5％ and 42.9％,the2 - year recurrence rate were 14.3％,14.6％,5％ and 52.4％,the 3 - year recurrence rate were 18.4％,22.0％,10％ and 57.1％,the 4 - year recurrence rate were 22.5％,24.4％,15％ and 66.7％,and the 5 - year recurrence rate were 24.3％,26.8％,17.5％ and 71.4％ respectivelyConclusions The intravescal instillaton of THP associated with HCPT is an effective and safe treatment for superficial bladder cancer.It may be a potential better method of intravescial instillation of bladder cancer.